NCT03719729 Rifaximin to Modify the Disease Course in Sickle Cell Disease Status UNKNOWN Phase PHASE2
NCT03715972 Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia Status COMPLETED Phase N/A
NCT03709303 Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research Status COMPLETED Phase N/A
NCT03708731 Exploring Adherence Monitoring in Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03694548 Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease Status TERMINATED Phase NA
NCT03682211 Intranasal Fentanyl Versus Intravenous Morphine in the Treatment of Severe Painful Sickle Cell Crises in Children Status COMPLETED Phase PHASE4
NCT03664830 Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03653676 Sickle Cell Pro-Inflammatory Response to Interval Training Study Status COMPLETED Phase N/A
NCT03653247 A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT03648710 Community Health Workers and mHealth for Sickle Cell Disease Care Status COMPLETED Phase NA
NCT03629678 Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease Status COMPLETED Phase NA
NCT03621826 Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease Status COMPLETED Phase N/A
NCT03615924 Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease Status TERMINATED Phase PHASE3
NCT03609840 Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients Status COMPLETED Phase N/A
NCT03609827 Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients Status COMPLETED Phase N/A